Marcus E. Peter

50.1k total citations · 14 hit papers
180 papers, 28.7k citations indexed

About

Marcus E. Peter is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Marcus E. Peter has authored 180 papers receiving a total of 28.7k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Molecular Biology, 57 papers in Immunology and 51 papers in Cancer Research. Recurrent topics in Marcus E. Peter's work include Cell death mechanisms and regulation (72 papers), RNA Interference and Gene Delivery (42 papers) and MicroRNA in disease regulation (32 papers). Marcus E. Peter is often cited by papers focused on Cell death mechanisms and regulation (72 papers), RNA Interference and Gene Delivery (42 papers) and MicroRNA in disease regulation (32 papers). Marcus E. Peter collaborates with scholars based in United States, Germany and France. Marcus E. Peter's co-authors include Peter H. Krammer, Carsten Scaffidi, Ernst Lengyel, Sun-Mi Park, Frank Kischkel, Arti Gaur, Andrea E. Murmann, Bryan C. Barnhart, Robert Schickel and Erich A. Nigg and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Marcus E. Peter

180 papers receiving 28.2k citations

Hit Papers

FLICE, A Novel FADD-Homol... 1990 2026 2002 2014 1996 2008 2011 1995 1997 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling Complex
    1996 2.6k citations Marcus E. Peter et al. profile →
  2. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2
    2008 1.9k citations Sun-Mi Park, Ernst Lengyel et al. profile →
  3. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
    2011 1.7k citations Hilary A. Kenny, Marion Zillhardt et al. profile →
  4. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor.
    1995 1.7k citations Marcus E. Peter et al. profile →
  5. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
    1997 1.1k citations Marcus E. Peter et al. profile →
  6. The CD95(APO-1/Fas) DISC and beyond
    2003 846 citations Marcus E. Peter et al. profile →
  7. Apoptosis signaling by death receptors
    1998 815 citations Marcus E. Peter et al. profile →
  8. The Role of c-FLIP in Modulation of CD95-induced Apoptosis
    1999 687 citations Marcus E. Peter et al. profile →
  9. In vitro disassembly of the nuclear lamina and M phase-specific phosphorylation of lamins by cdc2 kinase
    1990 663 citations Marcus E. Peter et al. profile →
  10. FADD/MORT1 Is a Common Mediator of CD95 (Fas/APO-1) and Tumor Necrosis Factor Receptor-induced Apoptosis
    1996 653 citations Marcus E. Peter et al. profile →
  11. MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death
    2008 614 citations Marcus E. Peter et al. profile →
  12. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death
    2005 598 citations Marcus E. Peter et al. profile →
  13. The role of let-7 in cell differentiation and cancer
    2009 540 citations Benjamin Boyerinas, Sun-Mi Park et al. profile →
  14. Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells
    1999 523 citations Marcus E. Peter et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Marcus E. Peter 21.6k 8.5k 7.3k 5.5k 2.8k 180 28.7k
Henning Walczak 18.5k 0.9× 5.6k 0.7× 10.7k 1.5× 5.3k 1.0× 3.9k 1.4× 207 26.5k
Robert T. Abraham 20.2k 0.9× 4.4k 0.5× 5.9k 0.8× 7.5k 1.4× 1.9k 0.7× 215 29.0k
Andrew Wakeham 17.3k 0.8× 5.6k 0.7× 13.3k 1.8× 7.9k 1.4× 2.0k 0.7× 112 31.5k
John L. Cleveland 14.8k 0.7× 3.3k 0.4× 4.7k 0.7× 6.8k 1.3× 3.3k 1.2× 224 22.7k
Dario C. Altieri 22.4k 1.0× 4.5k 0.5× 5.8k 0.8× 9.0k 1.6× 2.1k 0.8× 256 31.2k
Karen O’Rourke 15.5k 0.7× 4.3k 0.5× 7.8k 1.1× 3.5k 0.6× 2.1k 0.7× 44 20.2k
Peter Angel 17.7k 0.8× 6.1k 0.7× 5.1k 0.7× 5.9k 1.1× 1.3k 0.5× 186 29.1k
David Wallach 11.8k 0.5× 4.6k 0.5× 10.6k 1.5× 3.6k 0.7× 2.9k 1.0× 172 22.0k
John Silke 15.6k 0.7× 3.6k 0.4× 6.8k 0.9× 3.5k 0.6× 2.7k 1.0× 188 19.8k
Srinivasa M. Srinivasula 18.1k 0.8× 3.0k 0.4× 5.6k 0.8× 3.1k 0.6× 3.3k 1.2× 105 23.5k

Countries citing papers authored by Marcus E. Peter

Since Specialization
Citations

This map shows the geographic impact of Marcus E. Peter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus E. Peter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus E. Peter more than expected).

Fields of papers citing papers by Marcus E. Peter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcus E. Peter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus E. Peter. The network helps show where Marcus E. Peter may publish in the future.

Co-authorship network of co-authors of Marcus E. Peter

This figure shows the co-authorship network connecting the top 25 collaborators of Marcus E. Peter. A scholar is included among the top collaborators of Marcus E. Peter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcus E. Peter. Marcus E. Peter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bartom, Elizabeth T., John A. Kessler, Joseph R. Mazzulli, et al.. (2024). Death Induced by Survival gene Elimination (DISE) correlates with neurotoxicity in Alzheimer’s disease and aging. Nature Communications. 15(1). 264–264. 5 indexed citations
2.
Peter, Marcus E. & Maartje M. C. Bastings. (2024). Unfolding a death signal to treat rheumatoid arthritis. Nature Materials. 23(7). 882–883. 2 indexed citations
3.
Vaidyanathan, Aparajitha, Harry E. Taylor, Thomas J. Hope, et al.. (2023). Analysis of the Contribution of 6-mer Seed Toxicity to HIV-1-Induced Cytopathicity. Journal of Virology. 97(7). e0065223–e0065223. 4 indexed citations
4.
Peter, Marcus E., et al.. (2023). CD95/Fas ligand induced toxicity. Biochemical Society Transactions. 51(1). 21–29. 4 indexed citations
5.
Bartom, Elizabeth T., Masha Kocherginsky, Aparajitha Vaidyanathan, et al.. (2022). SPOROS: A pipeline to analyze DISE/6mer seed toxicity. PLoS Computational Biology. 18(3). e1010022–e1010022. 8 indexed citations
6.
7.
Patel, Monal, Yinu Wang, Elizabeth T. Bartom, et al.. (2021). The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer. Cancer Research. 81(15). 3985–4000. 15 indexed citations
8.
Patel, Monal, et al.. (2021). DISE/6mer seed toxicity-a powerful anti-cancer mechanism with implications for other diseases. Journal of Experimental & Clinical Cancer Research. 40(1). 389–389. 7 indexed citations
9.
Wang, Yinu, Guangyuan Zhao, Salvatore Condello, et al.. (2020). Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis. Cancer Research. 81(2). 384–399. 175 indexed citations
10.
Putzbach, William, Quan Q. Gao, Aishe A. Sarshad, et al.. (2018). CD95/Fas ligand mRNA is toxic to cells. eLife. 7. 23 indexed citations
11.
Murmann, Andrea E., Jindan Yu, Puneet Opal, & Marcus E. Peter. (2018). Trinucleotide Repeat Expansion Diseases, RNAi, and Cancer. Trends in cancer. 4(10). 684–700. 17 indexed citations
12.
Gao, Quan Q., William Putzbach, Andrea E. Murmann, et al.. (2018). 6mer seed toxicity in tumor suppressive microRNAs. Nature Communications. 9(1). 4504–4504. 28 indexed citations
13.
Putzbach, William, et al.. (2018). DISE: A Seed-Dependent RNAi Off-Target Effect That Kills Cancer Cells. Trends in cancer. 4(1). 10–19. 16 indexed citations
14.
Patel, Monal & Marcus E. Peter. (2017). Identification of DISE-inducing shRNAs by monitoring cellular responses. Cell Cycle. 17(4). 506–514. 9 indexed citations
15.
Putzbach, William, Quan Q. Gao, Monal Patel, et al.. (2017). Many si/shRNAs can kill cancer cells by targeting multiple survival genes through an off-target mechanism. eLife. 6. 46 indexed citations
16.
Eckert, Mark A., Shawn Pan, Kyle M. Hernandez, et al.. (2016). Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube. Cancer Discovery. 6(12). 1342–1351. 130 indexed citations
17.
Mitra, Anirban, Marion Zillhardt, Youjia Hua, et al.. (2012). MicroRNAs Reprogram Normal Fibroblasts into Cancer-Associated Fibroblasts in Ovarian Cancer. Cancer Discovery. 2(12). 1100–1108. 312 indexed citations
18.
Boyerinas, Benjamin, Sun-Mi Park, Noam Shomron, et al.. (2008). Identification of Let-7–Regulated Oncofetal Genes. Cancer Research. 68(8). 2587–2591. 188 indexed citations
19.
Sawada, Kenjiro, Anirban Mitra, A. Reza Radjabi, et al.. (2008). Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via α5-Integrin, which Is a Therapeutic Target. Cancer Research. 68(7). 2329–2339. 303 indexed citations
20.
Schraven, Burkhart & Marcus E. Peter. (1995). APO‐1(CD95)‐mediated apoptosis in Jurkat cells does not involve src kinases or CD45. FEBS Letters. 368(3). 491–494. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henning Walczak Breakdown of academic impact, for papers by Robert T. Abraham Breakdown of academic impact, for papers by Andrew Wakeham Breakdown of academic impact, for papers by John L. Cleveland Breakdown of academic impact, for papers by Dario C. Altieri Breakdown of academic impact, for papers by Karen O’Rourke Breakdown of academic impact, for papers by Peter Angel Breakdown of academic impact, for papers by David Wallach Breakdown of academic impact, for papers by John Silke Breakdown of academic impact, for papers by Srinivasa M. Srinivasula
Rankless by CCL
2026